section name header

Pronunciation

am-pi-SIL-in/sul-BAK-tam

Classifications

Therapeutic Classification: anti-infectives

Pharmacologic Classification: aminopenicillins beta lactamase inhibitors

Indications

REMS


Action

  • Binds to bacterial cell wall, resulting in cell death; spectrum is broader than that of penicillin. Addition of sulbactam increases resistance to beta-lactamases, enzymes produced by bacteria that may inactivate ampicillin.
Therapeutic effects:
  • Bactericidal action.

Spectrum:

Pharmacokinetics

Absorption: Well absorbed from IM sites.

Distribution: Ampicillin diffuses readily into bile, blister and tissue fluids. Poor CSF penetration unless meninges are inflamed.

Metabolism/Excretion: Ampicillin is variably metabolized by the liver (12–50%). Renal excretion is also variable. Sulbactam is eliminated unchanged in urine.

Protein Binding: Ampicillin: 28%; sulbactam: 38%.

Half-Life: Ampicillin: 1–1.8 hr; sulbactam: 1–1.3 hr.

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
IMrapid1 hr6–8 hr
IVimmediateend of infusion6–8 hr



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Route/Dosage

Renal Impairment

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

IV Administration:

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Unasyn

Code

NDC Code